These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25726684)

  • 1. [Characteristics of medical use of Korvazan® for restorative treatment of patients with myocardial infarction, counting the risk factors].
    Vakaliuk IP; Tymochko NB
    Lik Sprava; 2013 Dec; (8):94-9. PubMed ID: 25726684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of carvedilol on parameters of myocardial perfusion in patients with left ventricular remodeling after myocardial infarction].
    Kardiologiia; 2009; 49(2):66. PubMed ID: 19254220
    [No Abstract]   [Full Text] [Related]  

  • 3. Carvedilol following AMI.
    Herner SJ; Seaton TL
    J Fam Pract; 1997 Oct; 45(4):288-9. PubMed ID: 9379146
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardioprotective effects of the vasodilator/beta-adrenoceptor blocker, carvedilol, in two models of myocardial infarction in the rat.
    Smith EF; Griswold DE; Hillegass LM; Slivjak MJ; Davis PA; DiMartino MJ
    Pharmacology; 1992; 44(6):297-305. PubMed ID: 1354874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of ramipril, carvedilol, and trimetazidine MR in improvement of quality of life of patients after myocardial infarction].
    Gafurova RM; Abdullaev AA; Kadieva IA; Islamova UA; Mutalipov KhM
    Kardiologiia; 2010; 50(12):15-8. PubMed ID: 21591386
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carvedilol in combined therapy of patients with Q myocardial infarction].
    Sadionchenko VS; Iakovleva MS; Shekhian GG; Mironova MA
    Ter Arkh; 2005; 77(8):14-9. PubMed ID: 16206599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of beta blockers, particularly carvedilol, on reducing the risk of events after acute myocardial infarction.
    Kopecky SL
    Am J Cardiol; 2006 Oct; 98(8):1115-9. PubMed ID: 17027583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A fairer comparison between carvedilol and metoprolol is still to be done].
    Johnsson G; Aberg J
    Lakartidningen; 2003 Oct; 100(44):3543-4, 3544-5. PubMed ID: 14651018
    [No Abstract]   [Full Text] [Related]  

  • 9. A frequent gene polymorphism affecting the heart-rate response to carvedilol.
    Eschenhagen T
    Pharmacogenomics; 2013 Jan; 14(2):115-8. PubMed ID: 23327570
    [No Abstract]   [Full Text] [Related]  

  • 10. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
    Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.
    Lancet; 1997 Feb; 349(9049):375-80. PubMed ID: 9033462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of carvedilol and atenolol efficacy in patients with stable effort angina].
    Martsevich SIu; Koniakhina IP; Alimova EV; Kutishenko NP; Lerman OV
    Ter Arkh; 2001; 73(1):38-41. PubMed ID: 11234138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].
    Costalunga A; Gavazzi A
    Ital Heart J Suppl; 2001 Nov; 2(11):1246-7. PubMed ID: 11775420
    [No Abstract]   [Full Text] [Related]  

  • 14. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.
    Sackner-Bernstein JD
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S25-9. PubMed ID: 14564231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are all beta-adrenoblockers equally effective? Place of carvedilol in the treatment of cardiovascular diseases].
    Tereshchenko SN; Zhirov IV
    Ter Arkh; 2007; 79(4):86-90. PubMed ID: 17564027
    [No Abstract]   [Full Text] [Related]  

  • 16. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
    Swedberg K
    Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
    [No Abstract]   [Full Text] [Related]  

  • 17. Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study.
    Bagriy AE; Schukina EV; Samoilova OV; Pricolota OA; Malovichko SI; Pricolota AV; Bagriy EA
    Adv Ther; 2015 Feb; 32(2):108-19. PubMed ID: 25700807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of carvedilol on atrial connexin 40 after myocardial infarction.
    Cao F; Huang C; Jiang H; Li X; Bao M; Tang Y
    Acta Cardiol; 2008 Jun; 63(3):303-8. PubMed ID: 18664019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative study in heart failure. Which beta blocker saves more life time?].
    MMW Fortschr Med; 2003 Oct; 145(40):52. PubMed ID: 14603606
    [No Abstract]   [Full Text] [Related]  

  • 20. Carvedilol versus metoprolol in the acute phase of myocardial infarction:
    Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
    Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.